| Dr Kyle Lee James, MD | |
|
4200 Nelson Rd, Lake Charles, LA 70605-4118 | |
| (337) 794-7790 | |
| Not Available |
| Full Name | Dr Kyle Lee James |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 27 Years |
| Location | 4200 Nelson Rd, Lake Charles, Louisiana |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194764464 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 023708 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus Ochsner Lake Area Hospital | Lake charles, LA | Hospital |
| West Calcasieu Cameron Hospital | Sulphur, LA | Hospital |
| Oakdale Community Hospital | Oakdale, LA | Hospital |
| Amd Healthcare Lc, Llc | Lake charles, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Leatherwood Emergency Group Llc | 0749521250 | 13 |
| Eunice Emergency Group Llc | 3476507849 | 12 |
| Calcasieu Emergency Group Llc | 4183651425 | 23 |
News Archive
The Food and Drug Administration defended its approval process for medical devices during a congressional hearing Thursday and said industry comparisons with Europe are off the mark.
Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
The cool, crisp air will soon be filled with the tantalizing scent of fried candy bars, funnel cakes and candy apples. Local and state fairs may offer thrilling rides and fun games, but perhaps the biggest attraction is the food.
There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of older and disabled Americans is essential. These goals are not incompatible, but they require a judicious approach to policy making that is depressingly absent in Washington.
› Verified 8 days ago
| Entity Name | Eunice Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104895689 PECOS PAC ID: 3476507849 Enrollment ID: O20050309000026 |
News Archive
The Food and Drug Administration defended its approval process for medical devices during a congressional hearing Thursday and said industry comparisons with Europe are off the mark.
Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
The cool, crisp air will soon be filled with the tantalizing scent of fried candy bars, funnel cakes and candy apples. Local and state fairs may offer thrilling rides and fun games, but perhaps the biggest attraction is the food.
There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of older and disabled Americans is essential. These goals are not incompatible, but they require a judicious approach to policy making that is depressingly absent in Washington.
› Verified 8 days ago
| Entity Name | Professional Emergency Physician Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992758247 PECOS PAC ID: 1759317092 Enrollment ID: O20050708000778 |
News Archive
The Food and Drug Administration defended its approval process for medical devices during a congressional hearing Thursday and said industry comparisons with Europe are off the mark.
Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
The cool, crisp air will soon be filled with the tantalizing scent of fried candy bars, funnel cakes and candy apples. Local and state fairs may offer thrilling rides and fun games, but perhaps the biggest attraction is the food.
There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of older and disabled Americans is essential. These goals are not incompatible, but they require a judicious approach to policy making that is depressingly absent in Washington.
› Verified 8 days ago
| Entity Name | Calcasieu Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215996467 PECOS PAC ID: 4183651425 Enrollment ID: O20050719000705 |
News Archive
The Food and Drug Administration defended its approval process for medical devices during a congressional hearing Thursday and said industry comparisons with Europe are off the mark.
Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
The cool, crisp air will soon be filled with the tantalizing scent of fried candy bars, funnel cakes and candy apples. Local and state fairs may offer thrilling rides and fun games, but perhaps the biggest attraction is the food.
There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of older and disabled Americans is essential. These goals are not incompatible, but they require a judicious approach to policy making that is depressingly absent in Washington.
› Verified 8 days ago
| Entity Name | Lake Charles Urgent Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306135892 PECOS PAC ID: 1052580644 Enrollment ID: O20110817000061 |
News Archive
The Food and Drug Administration defended its approval process for medical devices during a congressional hearing Thursday and said industry comparisons with Europe are off the mark.
Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
The cool, crisp air will soon be filled with the tantalizing scent of fried candy bars, funnel cakes and candy apples. Local and state fairs may offer thrilling rides and fun games, but perhaps the biggest attraction is the food.
There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of older and disabled Americans is essential. These goals are not incompatible, but they require a judicious approach to policy making that is depressingly absent in Washington.
› Verified 8 days ago
| Entity Name | Professional Emergency Medicine Management -- Lake Charles Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023430766 PECOS PAC ID: 7012131378 Enrollment ID: O20140609000077 |
News Archive
The Food and Drug Administration defended its approval process for medical devices during a congressional hearing Thursday and said industry comparisons with Europe are off the mark.
Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
The cool, crisp air will soon be filled with the tantalizing scent of fried candy bars, funnel cakes and candy apples. Local and state fairs may offer thrilling rides and fun games, but perhaps the biggest attraction is the food.
There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of older and disabled Americans is essential. These goals are not incompatible, but they require a judicious approach to policy making that is depressingly absent in Washington.
› Verified 8 days ago
| Entity Name | Calcasieu Cameron Emergency Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699167478 PECOS PAC ID: 3476871815 Enrollment ID: O20150414002039 |
News Archive
The Food and Drug Administration defended its approval process for medical devices during a congressional hearing Thursday and said industry comparisons with Europe are off the mark.
Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
The cool, crisp air will soon be filled with the tantalizing scent of fried candy bars, funnel cakes and candy apples. Local and state fairs may offer thrilling rides and fun games, but perhaps the biggest attraction is the food.
There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of older and disabled Americans is essential. These goals are not incompatible, but they require a judicious approach to policy making that is depressingly absent in Washington.
› Verified 8 days ago
| Entity Name | Sound Physicians Emergency Medicine Of Louisiana Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396253407 PECOS PAC ID: 1759642739 Enrollment ID: O20180308001149 |
News Archive
The Food and Drug Administration defended its approval process for medical devices during a congressional hearing Thursday and said industry comparisons with Europe are off the mark.
Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
The cool, crisp air will soon be filled with the tantalizing scent of fried candy bars, funnel cakes and candy apples. Local and state fairs may offer thrilling rides and fun games, but perhaps the biggest attraction is the food.
There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of older and disabled Americans is essential. These goals are not incompatible, but they require a judicious approach to policy making that is depressingly absent in Washington.
› Verified 8 days ago
| Entity Name | Leatherwood Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760946313 PECOS PAC ID: 0749521250 Enrollment ID: O20190410002335 |
News Archive
The Food and Drug Administration defended its approval process for medical devices during a congressional hearing Thursday and said industry comparisons with Europe are off the mark.
Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
The cool, crisp air will soon be filled with the tantalizing scent of fried candy bars, funnel cakes and candy apples. Local and state fairs may offer thrilling rides and fun games, but perhaps the biggest attraction is the food.
There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of older and disabled Americans is essential. These goals are not incompatible, but they require a judicious approach to policy making that is depressingly absent in Washington.
› Verified 8 days ago
| Entity Name | Avail Doctors Lc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053830596 PECOS PAC ID: 1759623721 Enrollment ID: O20190424000692 |
News Archive
The Food and Drug Administration defended its approval process for medical devices during a congressional hearing Thursday and said industry comparisons with Europe are off the mark.
Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
The cool, crisp air will soon be filled with the tantalizing scent of fried candy bars, funnel cakes and candy apples. Local and state fairs may offer thrilling rides and fun games, but perhaps the biggest attraction is the food.
There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of older and disabled Americans is essential. These goals are not incompatible, but they require a judicious approach to policy making that is depressingly absent in Washington.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kyle Lee James, MD 200 Corporate Blvd, Suite 201, Lafayette, LA 70508-3870 Ph: (800) 893-9698 | Dr Kyle Lee James, MD 4200 Nelson Rd, Lake Charles, LA 70605-4118 Ph: (337) 794-7790 |
News Archive
The Food and Drug Administration defended its approval process for medical devices during a congressional hearing Thursday and said industry comparisons with Europe are off the mark.
Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo.
Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients.
The cool, crisp air will soon be filled with the tantalizing scent of fried candy bars, funnel cakes and candy apples. Local and state fairs may offer thrilling rides and fun games, but perhaps the biggest attraction is the food.
There is no way to wrestle down the deficit without reining in Medicare costs. Ensuring that the program provides quality health care coverage to millions of older and disabled Americans is essential. These goals are not incompatible, but they require a judicious approach to policy making that is depressingly absent in Washington.
› Verified 8 days ago
Dr. Robert Michael Anderson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1701 Oak Park Blvd, Lake Charles, LA 70601 Phone: 337-494-2086 Fax: 337-430-6983 | |
Melvin Joseph Marque Iii, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1905 Country Club Rd, Lake Charles, LA 70605 Phone: 337-990-8000 | |
Dr. Gina Luisa Greco-angelopoulos, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2640 Country Club Rd, Suite 400, Lake Charles, LA 70605 Phone: 815-713-2600 | |
Dr. William G Hathaway Iii, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 524 S Ryan St, Lake Charles, LA 70601 Phone: 337-491-7755 | |
Mr. Jon Harvey Gray, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1701 Oak Park Blvd., Lake Charles, LA 70601 Phone: 337-494-3036 Fax: 337-494-2181 | |
Jane Smeck, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1905 Country Club Rd, Lake Charles, LA 70605 Phone: 337-990-8000 Fax: 337-990-8010 |